The Food and Drugs Authority has provided technical support to the Netherlands Pharmacovigilance Centre (LAREB) to provide Qualified Persons for Pharmacovigilance (QPPV) training.
The training is for regulators from the National Medicine Regulatory Authorities (NMRAs) of four African countries namely; Ethiopian Food and Drugs Authority, Pharmacy and Poisons Board (Kenya), Rwanda Food and Drugs Authority, and Tanzania Medicines and Medical Devices Authority under the PROFORMA Project
The six-day virtual training under the theme "Teach the Teacher for QPPV" had the goal to equip the regulators with the knowledge to be able to develop country-specific QPPV training and implementation plans tailored to address country-related pharmacovigilance challenges.
The training was attended by over 45 participants with staff from the NMRAs as well as participants from some Medical Universities such as Addis Ababa University (Ethiopia), Muhimbili University of Health and Allied Sciences (Tanzania), University of Nairobi (Kenya), and the University of Rwanda.
FDA facilitated a session on the underlisted:
- Roles and responsibilities of QPPVs,
- Purpose and evaluation of regulatory documents including Periodic Safety Update of Reports (PSUR/PBRER) and Risk Management Plans (RMPs)
- Principles of benefits and risks evaluation in the review of these documents.
- Pharmacovigilance inspections and audits
In addition to the formal presentations, the FDA was able to share its experience in the implementation of legal pharmacovigilance requirements for marketing authorization holders.
The FDA implemented the QPPV concept in 2015 and has since trained 172 QPPV and conducted over 71 Good Pharmacovigilance Practice Inspection.
The FDA is a Regional Centre of Regulatory Excellence (RCORE) for pharmacovigilance and in 2021, the FDA’s vigilance function was assessed as Maturity level 4 based on the WHO Global Benchmarking Tool.
This is the highest level of the ranking system.
The FDA looks forward to continuously contributing to the development and strengthening of pharmacovigilance activities in Africa and globally to ensure patient safety.
Latest Stories
-
Samuel Boadu charged for misconduct in FA Cup semi-final clash with Kotoko
56 minutes -
DCOP Lydia Donkor, Gordon Saah and other new executives to lead armwrestling in Greater Accra
1 hour -
Amankona, Afriyie, and two other Berekum Chelsea players charged for misconduct in FA Cup semi-final
1 hour -
NPP lacks moral ground to criticise Sammy Gyamfi – Gbande fires back amid dollar gift controversy
1 hour -
Education Ministry to settle SD Dombo University’s ECG debt as new council takes office
1 hour -
Patriotic Action Forum demands dismissal of Sammy Gyamfi over dollar gift
2 hours -
Yam prices surge at Dambai market as season unfolds
2 hours -
Man who petitioned CHRAJ over Sammy Gyamfi’s dollar gift alleges threats on his life
2 hours -
African scientists defend research on solar geoengineering amidst misrepresentation claims
2 hours -
Ghana’s U-15 star John Andor set for two-month trial with Santos academy in Brazil
2 hours -
Mustapha Gbande apologises for Sammy Gyamfi’s cash gift, vows it will not recur
2 hours -
NPP overreaching by comparing Cecilia Dapaah’s case to Sammy Gyamfi’s dollar gift – Appiagyei-Atua
2 hours -
Dismissing or reassigning Sammy Gyamfi will set a strong precedent – Prof Appiagyei-Atua
2 hours -
Leadership and leniency: compassion is vital
2 hours -
Richmond Adu-Poku: New government, same old challenges in creative industry
2 hours